High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome
High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome
复制标题
高水平visfatin及Akt、ERK1/2信号通路激活与多囊卵巢综合征子宫内膜恶变相关
DOI:
10.1080/09513590.2019.1650340
复制
发表时间:
2020-02
影响因子:
2
通讯作者:
Zhang Huiying
中科院分区:
文献类型:
--
作者:
Tian Wenyan;Zhang Huixia;Zhang Yan;Wang Yingmei;Zhang Yanfang;Xue Fengxia;Song Xueru;Zhang Huiying
Abstract This study aimed to assess the clinicopathological significance of serum levels and endometrium tissue expression of visfatin in polycystic ovary syndrome (PCOS) patients. A total of 80 PCOS patients and 80 matching controls were included in this study. We analyzed the relationship between the expression of visfatin in endometrium and clinicopathological characteristics in PCOS patients. The correlation between the expression of visfatin and p-Akt, Akt, p-ERK1/2, and ERK1/2 in PCOS tissues was evaluated as well. Visfatin expression in PCOS endometrial tissues were significantly higher than those in controls (p = .001). The expression of phosphorylation of Akt and ERK1/2 were significantly higher in PCOS endometrium tissues compared to controls (p < .05). Moreover, a high expression of tissue visfatin in PCOS tissues was positively correlated with the expression of p-Akt (p = .015), and p-ERK1/2 (p = .013). Western blotting revealed that protein expression of visfatin in PCOS patients with endometrial hyperplasia and cancer was higher than that in patients with normal endometrium tissues, and the difference was statistically significant (p = .027). The expression of p-Akt (p = .018) and p-ERK1/2 (p = .035) in PCOS patients with endometrial hyperplasia and cancer was significantly higher than that in patients with normal endometrium tissues. Visfatin may be a potential biomarker for endometrial malignant transformation in PCOS patients.
登录
查看更多内容
影响因子:
3.8
作者:
Lee, Yi-Chen;Yang, Yi-Hsin;Yuan, Shyng-Shiou F.
通讯作者:
Yuan, Shyng-Shiou F.
影响因子:
--
作者:
Cymbaluk-Płoska A;Chudecka-Głaz A;Pius-Sadowska E;Sompolska-Rzechuła A;Machaliński B;Menkiszak J
通讯作者:
Menkiszak J
影响因子:
6.7
作者:
Teede HJ;Misso ML;Costello MF;Dokras A;Laven J;Moran L;Piltonen T;Norman RJ;International PCOS Network
通讯作者:
International PCOS Network
影响因子:
3.8
作者:
Kim, Jae Geun;Kim, Eun Ok;Lee, Byung Ju
通讯作者:
Lee, Byung Ju
影响因子:
3.5
作者:
Hufton, SE;Moerkerk, PT;Hoogenboom, HR
通讯作者:
Hoogenboom, HR